Oxford Catalysts Group scores service agreement
Synthetic fuels company Oxford Catalysts has signed a service agreement with Mourik to provide catalyst handling services for the group's commercial Fischer-Tropsch (FT) reactors.
Synthetic fuels company Oxford Catalysts has signed a service agreement with Mourik to provide catalyst handling services for the group's commercial Fischer-Tropsch (FT) reactors.
The replacement, activation, and regeneration of the group's FT units is both quicker and easier than with competing FT technologies, thereby simplifying logistics and enabling improved asset utilisation, the firm said.
The agreement will ensure that the Oxford's customers receive preferred service and best available pricing for their catalyst handling requirements, it said.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Roy Lipski, Chief Executive Officer of Oxford Catalysts Group, added: "We are delighted to be able to provide catalyst life-cycle services to our customers through Mourik, a world leader in this field. This preferred relationship with Mourik is another element in place ensuring our readines for commercial roll out and the expected growth in sales."
NR
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
-
Energy bills to rise by 1.2% in January 2025
Energy bills are set to rise 1.2% in the New Year when the latest energy price cap comes into play, Ofgem has confirmed
By Dan McEvoy Published
-
Should you invest in Trainline?
Ticket seller Trainline offers a useful service – and good prospects for investors
By Dr Matthew Partridge Published